Edition:
United States

Akari Therapeutics PLC (AKTX.OQ)

AKTX.OQ on NASDAQ Stock Exchange Capital Market

2.33USD
3:59pm EST
Change (% chg)

$-0.03 (-1.27%)
Prev Close
$2.36
Open
$2.36
Day's High
$2.37
Day's Low
$2.32
Volume
45,019
Avg. Vol
64,369
52-wk High
$22.16
52-wk Low
$2.06

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2017 Sep '17 0.00 -0.009
Jun '17 0.00 -0.000
Mar '17 0.00 -0.011
FY 2016 Dec '16 0.00 -0.007
Sep '16 0.00 -0.000
Jun '16 0.00 -0.005
Mar '16 0.00 -0.003
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-18 2 0.00 0.00 0.00 --
Quarter Ending Jun-18 2 0.00 0.00 0.00 --
Year Ending Dec-18 3 0.00 0.00 0.00 0.00
Earnings (per share)
Quarter Ending Mar-18 1 -0.72 -0.72 -0.72 --
Quarter Ending Jun-18 1 -0.72 -0.72 -0.72 --
Year Ending Dec-18 2 -2.00 -1.21 -2.79 -4.82
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 187.16 35.64
P/E High - Last 5 Yrs. -- 283.01 46.80
P/E Low - Last 5 Yrs. -- 92.63 24.18
Beta -7.77 0.81 0.81
Price to Sales (TTM) -- 144.25 8.67
Price to Book (MRQ) 2.13 19.79 5.21
Price to Tangible Book (MRQ) 2.77 26.40 6.35
Price to Cash Flow (TTM) -- 124.99 26.03
% Owned Institutions 24.66 11.86 2.27

Dividends

  Company industry sector
Dividend Yield -- 0.28 1.51
Dividend Yield - 5 Year Avg -- 0.20 2.01
Dividend 5 Year Growth Rate -- 1.92 5.24
Payout Ratio(TTM) -- 8.43 44.74

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -- 19.88 9.21
Sales (TTM) vs TTM 1 Yr. Ago -- 61.01 7.55
Sales - 5 Yr. Growth Rate -- 32.71 10.21
EPS (MRQ) vs Qtr. 1 Yr. Ago -2,347.22 -97.85 16.86
EPS (TTM) vs TTM 1 Yr. Ago -827.68 -- --
EPS - 5 Yr. Growth Rate -- 46.54 11.51
Capital Spending - 5 Yr. Growth Rate -- 42.29 14.77

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 1.68 2.42
Current Ratio (MRQ) 2.38 5.73 3.38
LT Debt to Equity (MRQ) 0.00 16.72 12.01
Total Debt to Equity (MRQ) 0.00 18.87 15.38
Interest Coverage (TTM) -- -164.25 39.15

Profitability Ratios

  Company industry sector
Gross Margin (TTM) -- 51.19 54.84
Gross Margin - 5 Yr. Avg. -- 55.55 52.61
EBITD Margin (TTM) -- -- --
EBITD - 5 Yr. Avg -- -566.09 9.77
Operating Margin (TTM) -- -598.23 2.53
Operating Margin - 5 Yr. Avg. -- -587.15 5.00
Pre-Tax Margin (TTM) -- -568.90 3.34
Pre-Tax Margin - 5 Yr. Avg. -- -595.33 5.26
Net Profit Margin (TTM) -- -564.05 -0.18
Net Profit Margin - 5 Yr. Avg. -- -599.22 1.54
Effective Tax Rate (TTM) -- 0.16 22.12
Effective Tax Rate - 5 Yr. Avg. -- 17.90 24.22

Efficiency

  Company industry sector
Revenue/Employee (TTM) 0 23,686,315 822,216,427
Net Income/Employee (TTM) -2,104,482 -650,139 96,151,835
Receivable Turnover (TTM) -- 14.03 5.40
Inventory Turnover (TTM) -- 2.43 3.51
Asset Turnover (TTM) 0.00 0.39 0.90

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -84.75 -1.09 10.70
Return on Assets - 5 Yr. Avg. -69.68 -0.33 12.00
Return on Investment (TTM) -116.50 -0.71 13.57
Return on Investment - 5 Yr. Avg. -103.47 2.30 15.72
Return on Equity (TTM) -116.74 -3.52 15.19
Return on Equity - 5 Yr. Avg. -105.91 -1.79 16.94
  1 Year 3 Year 5 Year
Sales % -- -- --
EPS (TTM) % 71.04 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Akari Therapeutics PLC

Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 24.66%
# of Holders: 22
Total Shares Held: 3,762,396
3 Mo. Net Change: 1,434,590
# New Positions: 9
# Closed Positions: 1
# Increased Positions: 12
# Reduced Positions: 4
# Net Buyers: 8
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.